Richard Mauroner
Psychiatry · Chattanooga, TNNPI 1992813976
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 457 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,979 and has fallen 98.4% since, to $32 in 2025. Among psychiatry clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 457 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$633
- Neurocrine Biosciences, Inc.$628
- Johnson & Johnson$597
- Supernus Pharmaceuticals, Inc.$566
- AbbVie$560
- plus $3K from 23 others
What the payments were for
- Food & beverage$7,323100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 76 | $1,057 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $633 |
| Neurocrine Biosciences, Inc. | 46 | $628 |
| Johnson & Johnson | 37 | $597 |
| Supernus Pharmaceuticals, Inc. | 26 | $566 |
| AbbVie(2 entities) | 45 | $560 |
| Sunovion Pharmaceuticals Inc. | 33 | $543 |
| Lundbeck LLC | 23 | $391 |
| Teva Pharmaceuticals USA, Inc. | 18 | $306 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $282 |
| Alkermes, Inc. | 14 | $251 |
| Corium, LLC | 12 | $241 |
| Eisai Inc. | 14 | $221 |
| Vanda Pharmaceuticals Inc. | 8 | $180 |
| Neos Therapeutics, LP | 10 | $175 |
| Jazz Pharmaceuticals Inc. | 7 | $124 |
| Avanir Pharmaceuticals, Inc. | 4 | $105 |
| Bausch Health US, LLC | 5 | $79 |
| Almatica Pharma LLC | 4 | $64 |
| Adlon Therapeutics L.p. | 4 | $60 |
| Shire North American Group Inc | 4 | $57 |
| Ironshore Pharmaceuticals Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Tris Pharma Inc | 2 | $29 |
| Merck | 2 | $26 |
| Neuronetics, Inc. | 2 | $23 |
| Rhodes Pharmaceuticals L.p. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINTELLIX$113
How this compares
$7,323 in reported general payments places this provider in the 90th percentile of 503 psychiatry providers in Tennessee.
Other psychiatry in Chattanooga
- Kevin FergusonChattanooga$44K
- Oliver GregoryChattanooga$13K
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- John FenleyJohnson City$1.4M
- David SnowMaryville$605K
- Karthi NamasivayamKnoxville$225K
- Robert JamiesonNashville$141K
- George BrownJohnson City$91K
- Sricharan MoturiFranklin$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.